| scholarly article | Q13442814 |
| P50 | author | Amanda E Ramer-Tait | Q42426185 |
| P2093 | author name string | Balaji Narasimhan | |
| Krishna Rajan | |||
| Bret D Ulery | |||
| Michael J Wannemuehler | |||
| Latrisha K Petersen | |||
| Scott R Broderick | |||
| Chang-Sun Kong | |||
| P433 | issue | 28 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 6815-6822 | |
| P577 | publication date | 2011-06-24 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants | |
| P478 | volume | 32 |
| Q64953705 | A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides. |
| Q41879397 | A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms |
| Q35887551 | Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen. |
| Q64951879 | Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. |
| Q47848180 | An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis |
| Q91780875 | An overview of biodegradable nanomaterials and applications in vaccines |
| Q36591050 | Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases |
| Q38131659 | Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses. |
| Q58114671 | Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery |
| Q42114702 | Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells |
| Q99565147 | Carbon Quantum Dots: In vitro and in vivo Studies on Biocompatibility and Biointeractions for Optical Imaging |
| Q36582010 | Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles |
| Q51567300 | Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant. |
| Q34417303 | Combinatorial Synthesis of and high-throughput protein release from polymer film and nanoparticle libraries |
| Q36957938 | Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery |
| Q64106279 | Design and synthesis of multivalent α-1,2-trimannose-linked bioerodible microparticles for applications in immune response studies of infection |
| Q93197903 | Determining Whether Agonist Density or Agonist Number Is More Important for Immune Activation via Micoparticle Based Assay |
| Q53755427 | Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches. |
| Q41382022 | Effect of nanovaccine chemistry on humoral immune response kinetics and maturation |
| Q47685899 | Effects of engineered nanoparticles on the innate immune system |
| Q50317606 | Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf |
| Q47248817 | Emerging trends in the immunotherapy of pancreatic cancer. |
| Q38154804 | Engineering synthetic vaccines using cues from natural immunity |
| Q90489301 | Evaluation of CpG-ODN-adjuvanted polyanhydride-based intranasal influenza nanovaccine in pigs |
| Q46989472 | Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery |
| Q37591932 | Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity |
| Q88576669 | From allergen to oral vaccine carrier: A new face of ragweed pollen |
| Q38757220 | Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants. |
| Q42426154 | Harvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticles |
| Q36317368 | High-throughput synthesis of carbohydrates and functionalization of polyanhydride nanoparticles |
| Q27021145 | Immunomodulation of nanoparticles in nanomedicine applications |
| Q34869890 | In silico design of anti-atherogenic biomaterials |
| Q28084818 | Informatics derived materials databases for multifunctional properties |
| Q57492118 | Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy |
| Q41389065 | Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours |
| Q46246924 | Maternal Vaccination. Immunization of Sows during Pregnancy against ETEC Infections |
| Q38418305 | Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine. |
| Q38257645 | Nanoparticle based-immunotherapy against allergy. |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q40050352 | Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses. |
| Q38693411 | Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen |
| Q39002525 | Polyanhydride nanovaccine against swine influenza virus in pigs |
| Q36598433 | Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation |
| Q47097020 | Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype |
| Q51732398 | Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity. |
| Q34871862 | Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles |
| Q41158336 | Self-Assembly Protein Nanogels for Safer Cancer Immunotherapy |
| Q50928936 | Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses. |
| Q90696345 | Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague |
| Q41718977 | Surface Coating of Nanoparticles Reduces Background Inflammatory Activity while Increasing Particle Uptake and Delivery |
| Q38982074 | Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation |
| Q28085375 | Synthetic Nanoparticles for Vaccines and Immunotherapy |
| Q40280801 | Synthetic nanovaccines for immunotherapy. |
| Q38722460 | The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response |
| Q42926219 | The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation |
Search more.